EROGENEX DENIES ADVERTISING AGREEMENT WITH GENESIS MEDIA GROUP INC. BUSINESS EDITORS LAS VEGAS--(BW HEALTHWIRE)--MAY 4, 1999--THE EROGENEX CORPORATION TODAY DENIED THAT IT HAS ENTERED INTO AN
--------------------------------------------------------------------------------
LAS VEGAS--(BW HealthWire)--May 4, 1999--The Erogenex Corporation
today denied that it has entered into an advertising agreement with
the Genesis Media Group Inc. (OTC:GNNX.O) to market its sexual
enhancement product known as Erogenex.
Erogenex Corp. President Art Bond stated that Erogenex Corp. has
been marketing its male and female formulas via its Internet site
(http://www.erogenex.com) and network of international distributors
since June of 1998 and does not plan to change its marketing
strategies.
Since it was first introduced nearly a year ago, Erogenex has
created tremendous excitement with its non-prescription sexual
enhancement products. Reports from users of Erogenex indicate that it
helps stimulate sexual desire, boosts libido, and increases endurance
and stamina.
Additionally, the Erogenex Corp. has been able to tap into a
large part of the market that has been dominated by Pfizer (NYSE:PFE.N),
makers of Viagra, due to the fact that its non-prescription formula
has no documented side-effects. Other companies, such as Zonagen
(Nasdaq:ZONA.O), Icos Corp (Nasdaq:ICOS.O), Bristol-Myers Squibb Company
(NYSE:BMY.N) and Eli Lilly (NYSE:LLY.N) continue working on similar drugs
that will also require a prescription.
The Erogenex Corporation believes its products are a safe and
smart alternative for those seeking help with sexual performance.
--30--ECQ/la* LS/la
CONTACT: Erogenex Corporation, Las Vegas
Art Bond, 702/248-1418
erogenex@erogenex.com
KEYWORD: NEVADA
INDUSTRY KEYWORD: MEDICINE PHARMACEUTICAL
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
Copyright 1999, Business Wire |
